Did Pfizer's Obesity Shot Do Well Enough To Catch Lilly? - Investor's Business Daily
Source:Investor's Business Daily
An analyst says Eli Lilly’s Zepbound still looks like the heavyweight in obesity.
Related Articles
Alphabet Stock Falls After Google's Parent Outlines AI Capex Boost - The Wall Street Journal
Alphabet shares fell more than 4% after Google’s parent company reported a jump in quarterly …
OpenAI Partners with Major Government Contractor to ‘Transform Federal Operations’ - Gizmodo
Leidos is a prolific government contractor with a “strong relationship with DHS.”
Waabi raises $1B and expands into robotaxis with Uber - TechCrunch
Waabi has secured a $750 million Series C round to accelerate autonomous trucking, and another …
Bitcoin drops below $70,000 as crypto selloff deepens before U.S. equity market opens - CoinDesk
“Extreme fear” grips crypto and metals while U.S. equities show resilience ahead of key …